Augmented Renal Clearance in Critical Illness: An Important Consideration in Drug Dosing
Top Cited Papers
Open Access
- 16 September 2017
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 9 (3), 36
- https://doi.org/10.3390/pharmaceutics9030036
Abstract
Augmented renal clearance (ARC) is a manifestation of enhanced renal function seen in critically ill patients. The use of regular unadjusted doses of renally eliminated drugs in patients with ARC might lead to therapy failure. The purpose of this scoping review was to provide and up-to-date summary of the available evidence pertaining to the phenomenon of ARC. A literature search of databases of available evidence in humans, with no language restriction, was conducted. Databases searched were MEDLINE (1946 to April 2017), EMBASE (1974 to April 2017) and the Cochrane Library (1999 to April 2017). A total of 57 records were included in the present review: 39 observational studies (25 prospective, 14 retrospective), 6 case reports/series and 12 conference abstracts. ARC has been reported to range from 14–80%. ARC is currently defined as an increased creatinine clearance of greater than 130 mL/min/1.73 m2 best measured by 8–24 h urine collection. Patients exhibiting ARC tend to be younger (<50 years old), of male gender, had a recent history of trauma, and had lower critical illness severity scores. Numerous studies have reported antimicrobials treatment failures when using standard dosing regimens in patients with ARC. In conclusion, ARC is an important phenomenon that might have significant impact on outcome in critically ill patients. Identifying patients at risk, using higher doses of renally eliminated drugs or use of non-renally eliminated alternatives might need to be considered in ICU patients with ARC. More research is needed to solidify dosing recommendations of various drugs in patients with ARC.Keywords
This publication has 60 references indexed in Scilit:
- A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrationsBMC Nephrology, 2013
- Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapyJournal of Critical Care, 2013
- Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?Critical Care, 2013
- Methaemoglobinaemia associated with the use of cocaine and volatile nitrites as recreational drugs: a reviewBritish Journal of Clinical Pharmacology, 2011
- A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearanceCritical Care, 2011
- Increased creatinine clearance in polytrauma patients with normal serum creatinine: a retrospective observational studyCritical Care, 2011
- Augmented Renal ClearanceClinical Pharmacokinetics, 2010
- Comparative Pharmacokinetics of the CarbapenemsClinical Pharmacokinetics, 2000
- Comparison of the renal effects of low to high doses of dopamine and dobutamine in critically ill patients: A single-blind randomized studyCritical Care Medicine, 2000
- Advancing Age and Acute Infection Influence the Kinetics of CeftazidimeScandinavian Journal of Infectious Diseases, 1989